In the search of molecularly targeted cancer therapy, tremendous interest has been given to the expression and regulation of the phosphodiesterase type 5 (PDE5) as an important signaling modulator involved in diverse aspects of tumor cell function. The gene discussed is PDE5A; the disease is cancer.